Accueil › Cancer colorectal › Colorado › Aurora
Essais cliniques pour Cancer colorectal à Aurora, CO
32 études pour Cancer colorectal recherchent des participants dans et autour de Aurora (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
Recrutement en coursPhase 3
- Rocky Mountain Cancer Centers - Aurora /ID# 280112, Aurora
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Recrutement en cours
- University of Colorado, Aurora
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Recrutement en coursPhase 3
- Rocky Mountain Cancer Centers, LLP, Aurora
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Recrutement en coursPhase 1/2
- University of Colorado Anschutz Medical Campus ( Site 0299), Aurora
- University of Colorado Anschutz Medical Campus ( Site 0325), Aurora
- University of Colorado Anschutz Medical Campus ( Site 0326), Aurora
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Recrutement en coursPhase 3
- University of Colorado Denver Anschultz Medical Campus, Aurora
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
Recrutement en coursPhase 1
- University of Colorado Denver Anschultz Medical Campus, Aurora
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Recrutement en coursPhase 3
- UCHealth University of Colorado Hospital, Aurora
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
Recrutement en coursPhase 1
- UCHealth University of Colorado Hospital, Aurora
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Recrutement en coursPhase 1/2
- University of Colorado Hospital-Anschutz Cancer Pavilion, Aurora
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Recrutement en coursPhase 1/2
- University of Colorado Cancer Center, Aurora
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Recrutement en coursPhase 1/2
- University of Colorado - Aurora Cancer Center, Aurora
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
Recrutement en coursPhase 1/2
- GSK Investigational Site, Aurora
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Recrutement en coursPhase 3
- Sarah Cannon Research Institute Scri Oncology Partners, Aurora
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
Recrutement en coursPhase 1
- University of Colorado Cancer Center, Aurora
Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
Recrutement en coursPhase 1/2
- UCHealth University of Colorado Hospital, Aurora
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1
- University of Colorado, Aurora
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Recrutement en coursPhase 1/2
- Children's Hospital Colorado, Aurora
Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- University of Colorado Denver, Aurora
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
Recrutement en coursPhase 2
- University of Colorado Hospital- Anschutz Cancer Center Pavillion (ACP), Aurora
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
Recrutement en coursÉtude observationnelle
- University of Colorado Anschutz Medical Center, Aurora
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1/2
- University of Colorado, Aurora
Novel Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer
Recrutement en coursVolontaires sains bienvenus
- University of Colorado Hospital, Aurora
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Recrutement en coursPhase 1
- University of Colorado, Aurora
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
Recrutement en coursPhase 1/2
- GSK Investigational Site, Aurora
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Recrutement en coursPhase 3
- Rocky Mountain Cancer Centers, LLP, Aurora
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Recrutement en coursPhase 1
- University of Colorado Hospital - Anschutz Cancer Pavilion (ACP), Aurora
- University of Colorado Hospital, Aurora
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1
- University of Colorado - Aurora Cancer Center, Aurora
LYL273 for Patients With Relapsed or Refractory mCRC
Recrutement en coursPhase 1/2
- University of Colorado Hospital - Anschutz Cancer Pavilion, Aurora
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Recrutement en coursPhase 1/2
- University of Colorado Cancer Center, Aurora
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Recrutement en coursÉtude observationnelle
- Rocky Mountain Cancer Centers-Aurora, Aurora
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
Recrutement en coursVolontaires sains bienvenus
- DARTNet Institute, Aurora
Essais pour Cancer colorectal dans d'autres villes
- Houston, TX102 études
- New York City, NY78 études
- Nashville, TN69 études
- Boston, MA63 études
- Los Angeles, CA59 études
- Arlington, VA52 études
- St. Louis, MO50 études
- San Antonio, TX46 études
- Philadelphia, PA44 études
- Grand Rapids, MI40 études
- Baldwin Park, CA37 études
- Chicago, IL34 études
Autres études à Aurora
- Cancer (tous types)35 études
- Cancer du poumon non à petites cellules31 études
- Cancer du sein28 études
- Cancer de l'ovaire25 études
- Cancer métastatique25 études
- Diabète de type 123 études
- Obésité22 études
- Cancer de la prostate19 études
- Cancer du poumon19 études
- Insuffisance cardiaque18 études
- Mélanome18 études
- Leucémie aiguë myéloïde16 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.